D. E. Shaw & Co., Inc. Gsk PLC Put Options Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $1.68 Million - $1.91 Million	-40,000 Reduced 44.44%	50,000 $2.18 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $804,599 - $954,800	20,000 Added 28.57%	90,000 $3.92 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $58,320 - $67,965	-1,500 Reduced 2.1%	70,000 $3.09 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $1.16 Million - $1.29 Million	-30,000 Reduced 29.56%	71,500 $2.73 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $1.67 Million - $1.89 Million	45,600 Added 81.57%	101,500 $4.04 Million
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $620,287 - $724,181	18,100 Added 47.88%	55,900 $2 Million
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $1.29 Million - $1.51 Million	37,800 New	37,800 $1.39 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.